Advertisement

Topics

Steadymed Submits New Drug Application for Trevyent

00:07 EDT 30 Jun 2017 | Drugs.com

SAN RAMON, Calif., June 30, 2017 (GLOBE NEWSWIRE) -- SteadyMed Ltd. (Nasdaq:STDY), a specialty pharmaceutical company focused on the development of drug product candidates to treat orphan and high-value diseases with unmet parenteral delivery needs,...

Original Article: Steadymed Submits New Drug Application for Trevyent

NEXT ARTICLE

More From BioPortfolio on "Steadymed Submits New Drug Application for Trevyent"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...